COVID-19 ACTION. INDUSTRIAL BASE EXPANSION OF CAPACITY FOR THE MANUFACTURE OF LIPIDS UTILIZED IN LIPID NANOPARTICLES (LNP) TECHNOLOGY FOR COVID VACCINES
$4,234,070FY2022Department of the ArmyDOD
Evonik Corporation
Investigators
View source on USAspending →COVID-19 ACTION. INDUSTRIAL BASE EXPANSION OF CAPACITY FOR THE MANUFACTURE OF LIPIDS UTILIZED IN LIPID NANOPARTICLES (LNP) TECHNOLOGY FOR COVID VACCINES · GrantIndex